Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Psoriatic Arthritis Clinical Trials
Psoriatic Arthritis clinical trials are recruiting across 93 cities. Here are the cities with the most active studies:
Psoriatic Arthritis Trial Phases
15 research organizations are sponsoring psoriatic arthritis trials.
About Psoriatic Arthritis
Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.
Clinical trials are advancing new treatments for psoriatic arthritis. Currently, 20 studies are recruiting a combined 7,683 participants across the United States. Research is being conducted by 15 organizations including Takeda, University of Michigan, AbbVie and 12 others.
2026 Psoriatic Arthritis Research Landscape
As of July 2026, the psoriatic arthritis clinical trial landscape includes 20 actively recruiting studies across 93 cities in the United States. These studies are collectively seeking 7,683 participants, with an average enrollment target of 384 per study.
The research spans multiple phases of development: 8 studies are in PHASE3, 3 studies are in PHASE2, 3 studies are in PHASE4, 2 studies are in PHASE1, 1 study is in NA. The presence of Phase 3 trials indicates that some psoriatic arthritis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 15 different organizations, including Takeda, University of Michigan, AbbVie, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and 10 others. The large number of sponsors reflects significant research interest and investment in psoriatic arthritis treatment advancement.
Geographically, psoriatic arthritis trials are most concentrated in Plantation, Florida (4 trials); Phoenix, Arizona (4 trials); Mesa, Arizona (4 trials); Tampa, Florida (4 trials); Tucson, Arizona (4 trials) and 7 other cities.
Featured Psoriatic Arthritis Studies
Highlighted recruiting studies for psoriatic arthritis, selected by enrollment size and research scope.
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) treatment period in one of the parent studies (TAK-279-PsA-3001 \[NCT06671483\] or TAK-279-PsA-3002 \...
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modifying antirheumatic drugs. The participants will be treated with either zasocitinib, active comparat...
EDRN Prostate MRI Biomarker Study
The commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This study will allow investigators to determine if prostate MRI is superior to validated panel of laboratory biomarkers (e....
Frequently Asked Questions About Psoriatic Arthritis Clinical Trials
Are there psoriatic arthritis clinical trials near me?
Yes, there are 20 psoriatic arthritis clinical trials currently recruiting across 93+ cities in the United States, including Plantation, Florida; Phoenix, Arizona; Mesa, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a psoriatic arthritis clinical trial?
To join a psoriatic arthritis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are psoriatic arthritis clinical trials free?
Yes, participation in psoriatic arthritis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of psoriatic arthritis treatments are being studied?
Current psoriatic arthritis clinical trials are testing a range of approaches across PHASE3 (8 studies), PHASE2 (3 studies), PHASE4 (3 studies), PHASE1 (2 studies), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 15 research organizations.
Is it safe to participate in psoriatic arthritis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov